The knockdown of MTBP in MHCC97-H cells accelerated the elimination of sorafenib in HCC cells or the subcutaneous tumor tissues, and the half-life time (t1/2 values) of sorafenib in HCC cells or tumor tissues was significantly reduced. The gene discussed is MTBP; the disease is neoplasm.